Home›Stock Screener›Vasundhara Rasayans

Vasundhara Rasayans Share Price Today | Stock Price & Vasundhara Rasayans Share Screener

VRL Pharmaceuticals
Live Share Price BSE
₹148.80
▲ 4.40 (3.05%)
2026-10-05 00:00:00

As of October 5, 2026, the live Vasundhara Rasayans share price (BSE: VRL) is ₹148.80, up 3.05% from the previous close, with shares trading between ₹138.00 and ₹157.00 in today's trading session, and a 52-week range of ₹105.65–₹213.15. Check VRL yearly price range for the annual price range and momentum. Use the Vasundhara Rasayans stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Vasundhara Rasayans opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.

Key Statistics and Valuation Ratios

Over the trailing twelve months the company reported revenue of ₹532 and net income of ₹-16, with EBITDA of ₹9, an operating margin of 2.0% and a profit margin of -3.0%.

Vasundhara Rasayans Market Cap ₹47.90 Cr.
VRL P/E Ratio (TTM) 8.11
Vasundhara Rasayans P/B Ratio 1.17
EPS (TTM) ₹18.22
Dividend Yield 1.33%
Debt to Equity 0.08
VRL 52 Week High ₹213.15
Vasundhara Rasayans 52 Week Low ₹105.65
Operating Margin 2.00%
Profit Margin -3.01%
VRL Revenue (TTM) ₹532.00
EBITDA ₹9.00
Net Income ₹-16.00
Total Assets ₹48.00
Total Equity ₹41.00

Vasundhara Rasayans Share Price Chart

Track the current stock price of Vasundhara Rasayans with an interactive chart. Analyse VRL share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Vasundhara Rasayans stock quote in one place.

The quote of ₹148.80 sits between the 52-week low of ₹105.65 and the 52-week high of ₹213.15, and the latest session moved 3.05% from the previous close.

Vasundhara Rasayans Company Profile - Fundamental Screener

Screen Vasundhara Rasayans company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for VRL shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Healthcare sector and the Pharmaceuticals industry, and it trades under ISIN INE406F01010.

Company Details

Classification

Sector Healthcare
Industry Pharmaceuticals
Sub-Sector Pharmaceuticals
Segment E

Identifiers and Leadership

ISIN INE406F01010

Vasundhara Rasayans Balance Sheet Screener

Screen VRL balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2026, total assets were ₹48, up from ₹43 in 2025.

Latest statistics put total assets at ₹48 and shareholder funds at ₹41, with a leverage ratio of 0.08.

Item 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017

Assets

Total Assets 48 43 37 35 26 23 25 21 20 14
Current Assets 45 40 35 34 24 13 24 21 20 7
Fixed Assets 2 3 2 1 1 1 0 0 0 7

Liabilities

Total Liabilities 0 0 0 0 0 0 0 0 0 0
Current Liabilities 0 1 1 0 0 1 0 0 0 1
Non-Current Liabilities 0 0 0 0 0 0 0 0 0 0

Shareholders' Equity

Total Equity 41 36 32 27 22 20 17 15 14 7
Share Capital 3 3 3 3 3 3 3 3 3 3
Reserves & Surplus 38 32 29 24 18 17 14 12 11 4

Vasundhara Rasayans Income Statement Screener - Profit & Revenue Analysis

Screen Vasundhara Rasayans income statement and profit fundamentals. Analyze VRL quarterly results. Vasundhara Rasayans reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For 2026-Mar, revenue was ₹532 and net profit was ₹-16, equal to earnings per unit of ₹-5.94, at an operating margin of 2%.

In that period expenses were ₹523, interest cost ₹15 and tax ₹-1. The next period listed, 2025-Dec, shows revenue of ₹988 and net profit of ₹11.

Item 2026-Mar 2025-Dec 2025-Mar

Revenue and Expenses

Revenue 532 988 774
Expenses 523 963 760

Operating Costs and Margins

EBITDA 9 25 14
Operating Profit % 2.00% 3.00% 3.00%
Depreciation 11 11 10
Interest 15 3 5

Profit and Earnings

Profit Before Tax -17 12 -1
Tax -1 1 0
Net Profit -16 11 -1
EPS -5.94 4.06 -0.41

Vasundhara Rasayans Cash Flow Screener - Liquidity Fundamentals

Screen VRL cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2026-March, operating activities used ₹2, and net cash flow was an outflow of ₹3.

Over the same period, investing activities provided ₹2 and financing activities used ₹3.

Item 2026-March 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March 2018-March 2017-March

Cash from Operations and Investing

Operating Activities -2 -6 6 -7 8 0 0 0 -11 2
Investing Activities 2 1 -1 1 1 0 1 1 13 0

Financing and Net Cash

Financing Activities -3 1 -3 2 1 -1 -1 -1 -2 -2
Net Cash Flow -3 -4 2 -3 10 0 1 0 0 0

Vasundhara Rasayans Shareholding Pattern Screener

See Vasundhara Rasayans shareholding pattern with promoter, FII, and DII holdings. Check Vasundhara Rasayans promoter holding and ownership changes for VRL on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Mar, promoters held 61.98%, foreign institutions 0.00%, domestic institutions 0.00% and the public 30.20%, spread across 6,006 shareholders.

The shareholder count was 6,006 in 2026-Mar, compared with 5,977 in 2026-Jun.

Item 2026-Mar 2026-Jun 2025-Mar 2025-Jun 2025-Sept 2025-Dec 2024-Mar 2024-Jun

Promoter Holding

Promoter Holding 61.98% 61.98% 61.98% 61.98% 61.98% 61.98% 61.98% 61.98%

Institutional Investors

FII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
DII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Government, Public and Others

Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 30.20% 30.31% 30.05% 30.04% 30.19% 29.66% 30.34% 30.38%
Other Holding 7.82% 7.71% 7.97% 7.97% 7.82% 8.36% 7.68% 7.64%
Shareholder Count 6,006 5,977 6,323 6,328 6,237 6,080 5,395 5,627

Dividend Yield Screener - Share Price & Share Analysis

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Vasundhara Rasayans. Vasundhara Rasayans dividend yield can be compared with peers and other stocks in the market.

The latest dividend recorded was ₹2.00 per unit for 2026-March, a yield of 1.26%, compared with ₹2.00 for 2025-March.

Dividends are listed for 10 periods, with the three most recent payouts at ₹2.00, ₹2.00 and ₹0.00 per unit.

Period Dividend Per Share Dividend Yield
2026-March ₹2.00 1.26%
2025-March ₹2.00 1.89%
2024-March ₹0.00 0.00%
2023-March ₹0.00 0.00%
2022-March ₹1.00 0.80%
2021-March ₹1.50 1.30%
2020-March ₹1.50 2.15%
2019-March ₹1.00 4.51%
2018-March ₹1.00 2.70%
2017-March ₹1.00 1.94%

Vasundhara Rasayans Stock Index Membership - Nifty & Sensex

See which indices include Vasundhara Rasayans stock. Check VRL index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

Complete Index List

Vasundhara Rasayans is not part of any tracked indices.
Only major market indices are tracked in our system.

Vasundhara Rasayans Market Events Screener - Corporate Actions

Get Vasundhara Rasayans corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Vasundhara Rasayans stock events that may affect VRL share price, along with derivatives, futures and options activity and sector gainers.

15 corporate actions are listed, the most recent entry being Annual General Meeting dated August 25, 2026, with a record date of August 25, 2026.

It is followed by Dividend dated August 18, 2026 and Quarterly Result Announcement dated August 14, 2026.

Announcement Date Record Date Event Type Information Price Impact
2026-08-25 2026-08-25 Annual General Meeting NA -13.23%
2026-08-18 2026-08-18 Dividend ₹ 2.00 /share -2.26%
2026-08-14 2026-08-14 Quarterly Result Announcement NA 5.13%
2026-05-28 2026-05-28 Quarterly Result Announcement NA 0.24%
2026-02-10 2026-02-10 Quarterly Result Announcement NA 9.35%
2025-11-13 2025-11-13 Quarterly Result Announcement NA -3.58%
2025-09-26 2025-09-26 Annual General Meeting NA 3.41%
2025-09-19 2025-09-19 Dividend ₹ 2.00 /share 5.28%
2025-08-13 2025-08-13 Quarterly Result Announcement NA -3.50%
2025-05-28 2025-05-28 Quarterly Result Announcement NA -3.21%
2025-02-10 2025-02-10 Quarterly Result Announcement NA -4.93%
2024-11-14 2024-11-14 Quarterly Result Announcement NA -3.00%
2024-09-30 2024-09-30 Annual General Meeting NA -3.19%
2024-09-23 2024-09-23 Dividend ₹ 2.00 /share -0.13%
2023-08-22 2023-08-23 Dividend ₹ 2.00 /share 43.94%

Vasundhara Rasayans Competitors Screener - Peer Stocks Comparison

Screen VRL competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Sun Pharmaceutical 440,998 36.44 61,674 12.69% 11,565 40.74
Divis Laboratories 253,523 86.51 11,067 13.95% 2,568 63.87
Torrent Pharmaceuticals 185,201 85.91 13,886 20.34% 2,138 46.50
Zydus Life Science 122,257 26.32 27,658 17.64% 5,026 66.57
Cipla 111,782 33.44 29,045 2.24% 3,870 45.42
Laurus Labs 108,549 99.70 6,868 22.01% 890 64.04
Dr Reddys Laboratories 101,913 32.05 35,059 3.90% 4,158 63.11
Mankind Pharma 100,589 48.73 14,636 14.85% 1,938 55.24
Aurobindo Pharma 97,670 26.36 34,145 5.56% 3,503 54.66
Lupin 94,281 16.99 29,039 26.75% 5,356 35.30

Vasundhara Rasayans Company Announcements - News & Reports Screener

Screen VRL latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated August 27, 2026.

The next most recent announcements are dated August 25, 2026 and August 16, 2026.

Date Update Actions
2026-08-27 Shareholder Meeting / Postal Ballot-Scrutinizer"s Report -
2026-08-25 Shareholder Meeting / Postal Ballot-Outcome of AGM -
2026-08-16 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-08-14 Financial Results For The Quarter Ended 30.06.2026 -
2026-08-14 Board Meeting Outcome for Outcome Of The Board Meeting Held On 14.08.2026 -
2026-08-06 Board Meeting Intimation for FINANCIAL RESULTS FOR THE QUARTER ENDED ON 30.06.2026 -
2026-08-04 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-08-01 Reg. 34 (1) Annual Report. -
2026-08-01 Notice Of 39Th Annual General Meeting Scheduled To Be Held On Tuesday 25Th August 2026 -
2026-08-01 Fixed Record Date For E-Voting In Connection With 39Th AGM -
2026-08-01 Announcement under Regulation 30 (LODR)-Change in Directorate -
2026-08-01 Board Meeting Outcome for Board Meeting Outcome For Outcome Of The Board Meeting Held On 01.08.2026 -
2026-07-28 Board Meeting Intimation for Recommend Dividend For The FY 2026-27 -
2026-07-22 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2026-06-30 Closure of Trading Window -
2026-05-30 Compliances-Reg.24(A)-Annual Secretarial Compliance -
2026-05-30 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-05-28 Announcement under Regulation 30 (LODR)-Change in Management -
2026-05-28 Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements -
2026-05-28 Intimation Under Reg 30 SEBI(LODR) 2015 Regarding Reconstitution Of Committees -

Frequently Asked Questions

How is the company valued right now?

The current quote is ₹148.80, within a 52-week range of ₹105.65 to ₹213.15. The P/E ratio is 8.11 and the P/B ratio is 1.17, with earnings per unit of ₹18.22. Market capitalisation stands at ₹47.90 Cr and the dividend yield is 1.33%. The company operates in the Healthcare sector, in the Pharmaceuticals industry, so compare these ratios with its sector peers in the table above.

About This Data

Quotes are sourced from the BSE. Key statistics were last updated on October 6, 2026. This page covers 10 balance sheet periods, 3 income statement periods, 10 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.